Tags

Type your tag names separated by a space and hit enter

Associations of metabolic syndrome with inflammation in CKD: results From the Third National Health and Nutrition Examination Survey (NHANES III).
Am J Kidney Dis 2005; 46(4):577-86AJ

Abstract

BACKGROUND

Although metabolic syndrome is associated with inflammation in the general population, it is unknown whether similar associations exist in patients with chronic kidney disease.

METHODS

+7 cross-sectional associations of metabolic syndrome and its component conditions (diabetes, hypertension, hypertriglyceridemia, abdominal obesity, and low high-density lipoprotein cholesterol level) with inflammation (C-reactive protein level > 3 mg/L) were examined by using logistic regression models in groups with high (>90 mL/min/1.73 m2 [>1.50 mL/s]), moderate (45 to 89 mL/min/1.73 m2 [0.75 to 1.49 mL/s]), and low (<45 mL/min/1.73 m2 [<0.75 mL/s]) creatinine clearances in 15,314 subjects participating in the Third National Health and Nutrition Examination Survey.

RESULTS

Adjusted for demographics, smoking, history of myocardial infarction or stroke, exercise level, and use of cholesterol medications, the presence of metabolic syndrome was associated with greater odds for inflammation in the groups with high (odds ratio, 2.55; 95% confidence interval [CI], 1.99 to 3.27), moderate (odds ratio, 2.17; 95% CI, 1.81 to 2.60), and low (odds ratio, 1.87; 95% CI, 1.36 to 2.56) creatinine clearances. When all 5 components of metabolic syndrome were included in the same model, only hypertension, abdominal obesity, and low high-density lipoprotein level were associated significantly with inflammation in all 3 groups. There also was a graded association between number of component conditions of metabolic syndrome and inflammation within each creatinine-clearance group.

CONCLUSION

Metabolic syndrome is associated with inflammation in patients with varying levels of kidney function. Future studies are warranted to determine in patients with chronic kidney disease whether there is a synergistic effect of metabolic syndrome and inflammation on the incidence of atherosclerotic events and whether interventions targeted toward metabolic syndrome might modulate inflammation.

Authors+Show Affiliations

Medical Service, Salt Lake Veterans Affairs Healthcare System, Salt Lake City, UT, USA. srinivasan.beddhu@hsc.utah.eduNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

16183411

Citation

Beddhu, Srinivasan, et al. "Associations of Metabolic Syndrome With Inflammation in CKD: Results From the Third National Health and Nutrition Examination Survey (NHANES III)." American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation, vol. 46, no. 4, 2005, pp. 577-86.
Beddhu S, Kimmel PL, Ramkumar N, et al. Associations of metabolic syndrome with inflammation in CKD: results From the Third National Health and Nutrition Examination Survey (NHANES III). Am J Kidney Dis. 2005;46(4):577-86.
Beddhu, S., Kimmel, P. L., Ramkumar, N., & Cheung, A. K. (2005). Associations of metabolic syndrome with inflammation in CKD: results From the Third National Health and Nutrition Examination Survey (NHANES III). American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation, 46(4), pp. 577-86.
Beddhu S, et al. Associations of Metabolic Syndrome With Inflammation in CKD: Results From the Third National Health and Nutrition Examination Survey (NHANES III). Am J Kidney Dis. 2005;46(4):577-86. PubMed PMID: 16183411.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Associations of metabolic syndrome with inflammation in CKD: results From the Third National Health and Nutrition Examination Survey (NHANES III). AU - Beddhu,Srinivasan, AU - Kimmel,Paul L, AU - Ramkumar,Nirupama, AU - Cheung,Alfred K, PY - 2005/04/28/received PY - 2005/06/16/accepted PY - 2005/9/27/pubmed PY - 2005/11/4/medline PY - 2005/9/27/entrez SP - 577 EP - 86 JF - American journal of kidney diseases : the official journal of the National Kidney Foundation JO - Am. J. Kidney Dis. VL - 46 IS - 4 N2 - BACKGROUND: Although metabolic syndrome is associated with inflammation in the general population, it is unknown whether similar associations exist in patients with chronic kidney disease. METHODS: +7 cross-sectional associations of metabolic syndrome and its component conditions (diabetes, hypertension, hypertriglyceridemia, abdominal obesity, and low high-density lipoprotein cholesterol level) with inflammation (C-reactive protein level > 3 mg/L) were examined by using logistic regression models in groups with high (>90 mL/min/1.73 m2 [>1.50 mL/s]), moderate (45 to 89 mL/min/1.73 m2 [0.75 to 1.49 mL/s]), and low (<45 mL/min/1.73 m2 [<0.75 mL/s]) creatinine clearances in 15,314 subjects participating in the Third National Health and Nutrition Examination Survey. RESULTS: Adjusted for demographics, smoking, history of myocardial infarction or stroke, exercise level, and use of cholesterol medications, the presence of metabolic syndrome was associated with greater odds for inflammation in the groups with high (odds ratio, 2.55; 95% confidence interval [CI], 1.99 to 3.27), moderate (odds ratio, 2.17; 95% CI, 1.81 to 2.60), and low (odds ratio, 1.87; 95% CI, 1.36 to 2.56) creatinine clearances. When all 5 components of metabolic syndrome were included in the same model, only hypertension, abdominal obesity, and low high-density lipoprotein level were associated significantly with inflammation in all 3 groups. There also was a graded association between number of component conditions of metabolic syndrome and inflammation within each creatinine-clearance group. CONCLUSION: Metabolic syndrome is associated with inflammation in patients with varying levels of kidney function. Future studies are warranted to determine in patients with chronic kidney disease whether there is a synergistic effect of metabolic syndrome and inflammation on the incidence of atherosclerotic events and whether interventions targeted toward metabolic syndrome might modulate inflammation. SN - 1523-6838 UR - https://www.unboundmedicine.com/medline/citation/16183411/Associations_of_metabolic_syndrome_with_inflammation_in_CKD:_results_From_the_Third_National_Health_and_Nutrition_Examination_Survey__NHANES_III__ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0272-6386(05)00901-7 DB - PRIME DP - Unbound Medicine ER -